Position in GH
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$264,802
New position
Shares Held
1,765
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#419
of 593 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Summit Financial, LLC holds $11,467,431 across 10 Diagnostics & Research names. GH ranks #8 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
11,435 | $3,104,030 | |
| 2 | GRAL |
GRAIL, Inc.
|
30,817 | $2,103,876 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
3,687 | $1,848,514 | |
| 4 | DHR |
Danaher Corp /De/
|
7,962 | $1,516,601 | |
| 5 | RDNT |
RadNet, Inc.
|
12,934 | $797,639 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
1,346 | $708,588 | |
| 7 | DGX |
Quest Diagnostics Inc
|
2,988 | $633,306 | |
| 8 | GH |
Guardant Health, Inc.
This page
|
1,765 | $264,802 |
All Filings in GH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $264,802 | 1,765 | Shares | Sole | 2026-08-12 | |
| No filing history on record for this holder in this stock. | ||||||